RapidPrint™ Series

About Aether Biomachines

Aether Biomachines is a private, Palo Alto-based company founded in 2019, positioning itself at the intersection of AI and synthetic biology to reindustrialize American manufacturing. It has developed a proprietary Protein Function Model trained on massive, in-house experimental data to predict and design proteins with novel functions for materials science and critical mineral processing. The company has launched initial commercial products for additive manufacturing, raised a $15M funding round, and is developing a pipeline of advanced materials and extraction technologies, targeting defense, aerospace, and industrial sectors.